Dr Lalchandani Labs Ltd.
| BSE: 541299 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE871Z01013 |
| BSE 00:00 | 29 Jun | 23.90 |
0 (0.00%) |
OPEN
22.00 |
HIGH
23.90 |
LOW
22.00 |
| NSE 05:30 | 01 Jan | Dr Lalchandani Labs Ltd |
| OPEN | 22.00 |
| PREVIOUS CLOSE | 23.90 |
| VOLUME | 12000 |
| 52-Week high | 52.50 |
| 52-Week low | 18.05 |
| P/E | 11.12 |
| Mkt Cap.(Rs cr) | 10 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Dr Lalchandani Labs Ltd. (DRLALCHANDLAB) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Aurobindo Pharma | 524.55 | 2.00 | 0.38 | 3112.91 |
| Cipla | 934.00 | -16.10 | -1.69 | 2468.28 |
| Dr Reddy's Labs | 4375.00 | -9.35 | -0.21 | 2186.40 |
| Sun Pharma.Inds. | 827.80 | 1.10 | 0.13 | 2139.70 |
| Divi's Lab. | 3639.80 | 5.00 | 0.14 | 1954.72 |
| Glaxosmi. Pharma | 1527.80 | 24.45 | 1.63 | 1690.53 |
| Alkem Lab | 3029.80 | 9.55 | 0.32 | 1685.08 |
| Glenmark Pharma. | 386.05 | -7.95 | -2.02 | 1649.45 |
| Zydus Lifesci. | 360.45 | -1.65 | -0.46 | 1476.20 |
| Lupin | 628.10 | -0.45 | -0.07 | 1258.62 |
| Alembic Pharma | 732.35 | 3.00 | 0.41 | 1175.39 |
| Ipca Labs. | 916.50 | 3.60 | 0.39 | 1140.77 |
| Torrent Pharma. | 2910.00 | -5.00 | -0.17 | 1137.85 |
| Gland Pharma | 2592.65 | -63.25 | -2.38 | 997.01 |
| Sanofi India | 6384.65 | 16.90 | 0.27 | 944.40 |
| Laurus Labs | 467.30 | 1.05 | 0.23 | 750.09 |
| Abbott India | 19000.00 | -81.95 | -0.43 | 690.69 |
| Ajanta Pharma | 1240.20 | -24.45 | -1.93 | 675.64 |
| Wockhardt | 208.05 | 0.35 | 0.17 | 593.29 |
| Granules India | 279.40 | 0.90 | 0.32 | 552.78 |
Quick Links for Dr Lalchandani Labs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
